BioCentury
ARTICLE | Company News

Amersham and P&G in proteomics deal

December 19, 2000 8:00 AM UTC

Nycomed Amersham (NYE; LSE:NAM) business Amersham Pharmacia Biotech (Piscataway, N.J.) and Procter & Gamble (PG) will develop PG's Peptide Derivatization Technology (PDT) for use with APBiotech's Etta...